Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Compumedics Limited ( (AU:CMP) ) is now available.
Compumedics Limited has announced the application for the quotation of 178,572 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from November 19, 2024. This move, part of a previously announced transaction, is expected to enhance the company’s financial standing and visibility in the market, potentially impacting its operations and stakeholder interests positively.
More about Compumedics Limited
Compumedics Limited operates in the medical technology industry, specializing in the development and commercialization of computer-based patient monitoring and diagnostic systems. The company focuses on sleep, brain, and ultrasonic blood-flow monitoring segments, catering to both clinical and research markets globally.
YTD Price Performance: 18.87%
Average Trading Volume: 47,257
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$60.49M
Learn more about CMP stock on TipRanks’ Stock Analysis page.
